
Join to View Full Profile
- 206 S Elmwood AveBuffalo, NY 14201 
- Phone+1 716-847-0212 
- Fax+1 716-847-2715 
Dr. Shon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 University at BuffaloFellowship, Infectious Disease, 2010 - 2012 University at BuffaloFellowship, Infectious Disease, 2010 - 2012
 Summa Health System/NEOMEDResidency, Internal Medicine, 2008 - 2010 Summa Health System/NEOMEDResidency, Internal Medicine, 2008 - 2010
 Northeast Ohio Medical UniversityClass of 2007 Northeast Ohio Medical UniversityClass of 2007
Certifications & Licensure
 NY State Medical License 2012 - 2027 NY State Medical License 2012 - 2027
 OH State Medical License 2008 - 2010 OH State Medical License 2008 - 2010
 American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Internal Medicine
 American Board of Internal Medicine Infectious Disease American Board of Internal Medicine Infectious Disease
Clinical Trials
- Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 2 citationsAntibody dependent cell cytotoxicity is maintained by the unmutated common ancestor of 6F5, a Gp41 conformational epitope targeting antibody that utilizes heavy chain ...Brian H Wrotniak, Meghan Garrett, Sarah Baron, Hakimuddin Sojar, Alyssa Shon
 Vaccine. 2022-07-29
- 64 citationsLong-acting cabotegravir + rilpivirine for HIV-1 treatment: ATLAS week 96 results.Susan Swindells, Thomas A. Lutz, Lelanie van Zyl, Norma Porteiro, Matthias Stoll
 AIDS. 2021-07-13
- 16 citationsPharmacokinetic drug interactions of integrase strand transfer inhibitorsChi-Hua Lu, Edward M. Bednarczyk, Linda M. Catanzaro, Alyssa Shon, Jia-Chen Xu
 Current Research in Pharmacology and Drug Discovery. 2021-01-01
Press Mentions
 Evergreen Health Debuts Cabenuva, First HIV Drug of Its Kind, Following FDA ApprovalMay 4th, 2021 Evergreen Health Debuts Cabenuva, First HIV Drug of Its Kind, Following FDA ApprovalMay 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









